TOTIENT

totient-logo

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

TOTIENT

Social Links:

Industry:
Artificial Intelligence Biotechnology Life Science Machine Learning

Founded:
2017-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.totient.bio

Total Employee:
11+

Status:
Active

Contact:
(617) 221-8986

Email Addresses:
[email protected]

Total Funding:
10 M USD

Technology used in webpage:
Amazon Google Apps For Business Amazon Route 53 Amazon CloudFront


Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

cytovale-logo

CytoVale

Categorized is a medical technology company that revolutionizes diagnostics using cell mechanics and machine learning.

dyno-therapeutics-logo

Dyno Therapeutics

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

kebotix-logo

Kebotix

Kebotix is a high-tech materials discovery and production company that reinvent the discovery of new materials using AI.

menten-ai-logo

Menten AI

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

protai-logo

Protai

Protai is an AI-powered drug discovery startup.

revivemed-logo

ReviveMed

ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites.

Current Employees Featured

deniz-kural_image

Deniz Kural
Deniz Kural CEO & Founder @ Totient
CEO & Founder
2017-03-01

Founder


deniz-kural_image

Deniz Kural

Investors List

cerracap-ventures_image

CerraCap Ventures

CerraCap Ventures investment in Venture Round - Totient

tachyon-ventures_image

Tachyon Ventures

Tachyon Ventures investment in Seed Round - Totient

viva-vision-biotech_image

Viva Biotech

Viva Biotech investment in Seed Round - Totient

andrey-izyumov-3f8a_image

Andrew Izyumov

Andrew Izyumov investment in Seed Round - Totient

sands-capital-ventures_image

Sands Capital Ventures

Sands Capital Ventures investment in Seed Round - Totient

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Seed Round - Totient

jonathan-milner_image

Jonathan Milner

Jonathan Milner investment in Seed Round - Totient

helicase-venture_image

Helicase Venture

Helicase Venture investment in Seed Round - Totient

tau-ventures-e0e2_image

Tau Ventures

Tau Ventures investment in Seed Round - Totient

bioinnovation-capital_image

Mission BioCapital

Mission BioCapital investment in Seed Round - Totient

Official Site Inspections

http://www.totient.bio

  • Host name: 172.67.152.111
  • IP address: 172.67.152.111
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Totient"

Totient - Viva BioInnovator

Totient enables next generation cell therapies and other therapeutic modalities by building the largest library of human-derived antibodies to novel and known tissue-specific antigens. The …See details»

About Us | Absci - totient.bio

Absci's vision is to deliver breakthrough therapeutics at the click of a button, for everyone. Learn about our team, values, and vision.See details»

Totient - Crunchbase Company Profile & Funding

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures.See details»

Totient, a Viva Biotech Portfolio Company, has been Acquired

Viva Biotech declared that Totient, one of its portfolio companies, has been acquired by AbSci, a synthetic biology company unlocking the potential of proteins as next-generation therapeutics.See details»

Totient - Part of Absci - LinkedIn

Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics.See details»

Totient Company Profile - Office Locations, Competitors ... - Craft

See insights on Totient including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

totient.bio: Revenue, Worth, Valuation & Competitors 2025

About totient.bio totient.bio is a Biotech related company founded in 2017 and based in Cambridge with 5 employees an estimated revenue of $775K, and. It has 10 competitors …See details»

Totient | Companies | RadialReport

Totient Companies AI-driven biotechnology companyAbout Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures.Totient - Crunchbase Company Profile & …See details»

Team | Absci - totient.bio

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.See details»

www.totient.bio

Www.totient.bioSee details»

Totient - Company info. interviews, news - BiopharmaTrend

Aug 18, 2022 Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity …See details»

Totient - Devex

Learn more about Totient's jobs, projects, latest news, contact information and geographical presence. About Totient is an AI-driven biotechnology company leveraging tertiary lymphoid …See details»

Totient, a Viva Biotech Portfolio Company, is Acquired by AbSci

VANCOUVER, Wash., June 14, 2021 --- AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced the acquisition of …See details»

Totient, a Viva Biotech Portfolio Company, Achieves the …

About Totient Totient is enabling next generation cell therapies and other therapeutic modalities by building the largest library of human-derived antibodies to novel and known tissue-specific …See details»

Totient 2025 Company Profile: Valuation, Investors, Acquisition

Information on acquisition, funding, cap tables, investors, and executives for Totient. Use the PitchBook Platform to explore the full profile.See details»

Totient - Financial Details - Crunchbase

Absci Founded 2017Private Venture - Series Unknown Cambridge, Massachusetts, United States 1-10 totient.bio/ Artificial Intelligence (AI) Biotechnology Life Science Machine Learning Totient …See details»

Totient - Tech Details - Crunchbase

Absci Founded 2017Private Venture - Series Unknown Cambridge, Massachusetts, United States 1-10 totient.bio/ Artificial Intelligence (AI) Biotechnology Life Science Machine Learning Totient …See details»

Totient - Growth Outlook - Crunchbase

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures.See details»

Totient Announces Formation of the New Scientific Advisory Board

Mar 24, 2021 We look forward to their contributions as Totient enters a new stage in building the deepest library of disease-derived tissue-specific immunogenic antigens and fully human …See details»

Totient - Wiki | Golden

AI Drug DiscoveryHelp us improve this page by adding information. Visit our Writing Guide or this topic page for additional help.See details»

linkstock.net © 2022. All rights reserved